Latest News about Eli Lilly and Co

Recent news which mentions Eli Lilly and Co

< Previous 1 2 3 4 5 6 7 8 9

...

Biogen advances Alzheimer's drug to late-stage trial despite disappointing data

May 14, 2026

Hantavirus outbreak isn't another Covid pandemic – but experts say it's testing U.S. readiness

May 14, 2026

Healthy Returns: Novo Nordisk says high-dose Wegovy helped some patients lose nearly 28% of their weight

May 12, 2026

Cramer's lightning round: Buy Caterpillar

May 11, 2026

Healthy Returns: First Ozempic generics in Canada will be a test case for Novo Nordisk

May 07, 2026

Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals

May 06, 2026

Wegovy sales smash forecasts after pill launch as Novo Nordisk hikes guidance

May 06, 2026

Iran tensions, Palantir earnings, Musk's SEC settlement and more in Morning Squawk

May 05, 2026

Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly's GLP-1 dominance

May 04, 2026

'Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds

May 04, 2026

Weight loss and hair loss: The growing hair treatment market from GLP-1s

May 02, 2026

Apple earnings, DHS shutdown, 'Ozempic breath' and more in Morning Squawk

May 01, 2026

Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data

August 26, 2025

Trump fires Fed's Cook, Musk sues Apple and OpenAI, Netflix's theatrical run and more in Morning Squawk

August 26, 2025

Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval

August 26, 2025

A world on weight loss drugs: How GLP-1s are reshaping the economy

August 26, 2025

Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors

August 24, 2025

CNBC's UK Exchange newsletter: The price is REIT

August 20, 2025

FDA approves first-ever glucose monitoring system for weight loss from Signos

August 20, 2025

Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data

August 19, 2025

Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients

August 18, 2025

'Don't quit the market' when it's frothy, says Jim Cramer. Here's why

August 14, 2025

Eli Lilly hikes price of diabetes drug Mounjaro in UK as Trump pressures pharma to align drug costs

August 14, 2025

Cramer's Lightning Round: Affirm is a buy

August 11, 2025

5 things to know before the Thursday open: Chip tariffs | Cook's White House visit | Wall Street's fashionista

August 07, 2025

Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar

August 07, 2025

Eli Lilly's obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for approval

August 07, 2025

Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakers

August 05, 2025

5 things to know before the Monday open: Berkshire's tariff fears | Ethereum turns 10 | Restaurants embrace spicy

August 04, 2025

Cramer's week ahead: Earnings from Palantir, Berkshire Hathaway, Disney and McDonald's

August 01, 2025

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.